These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24619702)

  • 1. Advances in host and vector development for the production of plasmid DNA vaccines.
    Mairhofer J; Lara AR
    Methods Mol Biol; 2014; 1139():505-41. PubMed ID: 24619702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmid DNA production for therapeutic applications.
    Lara AR; Ramírez OT; Wunderlich M
    Methods Mol Biol; 2012; 824():271-303. PubMed ID: 22160904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering Escherichia coli to increase plasmid DNA production in high cell-density cultivations in batch mode.
    Borja GM; Meza Mora E; Barrón B; Gosset G; Ramírez OT; Lara AR
    Microb Cell Fact; 2012 Sep; 11():132. PubMed ID: 22992433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering of Escherichia coli strains for plasmid biopharmaceutical production: scale-up challenges.
    Gonçalves GA; Prather KL; Monteiro GA; Prazeres DM
    Vaccine; 2014 May; 32(24):2847-50. PubMed ID: 24598722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering of bacterial strains and vectors for the production of plasmid DNA.
    Bower DM; Prather KL
    Appl Microbiol Biotechnol; 2009 Apr; 82(5):805-13. PubMed ID: 19205691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmid Replicons for the Production of Pharmaceutical-Grade pDNA, Proteins and Antigens by
    Duarte SOD; Monteiro GA
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of IS1 transposition in plasmid amplification mutants of E. coli clones producing DNA vaccines.
    Prather KL; Edmonds MC; Herod JW
    Appl Microbiol Biotechnol; 2006 Dec; 73(4):815-26. PubMed ID: 16941177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid DNA production with Escherichia coli GALG20, a pgi-gene knockout strain: fermentation strategies and impact on downstream processing.
    Gonçalves GA; Prather KL; Monteiro GA; Carnes AE; Prazeres DM
    J Biotechnol; 2014 Sep; 186():119-27. PubMed ID: 24995846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced plasmid DNA production by enzyme-controlled glucose release and an engineered Escherichia coli.
    Ramírez EA; Velázquez D; Lara AR
    Biotechnol Lett; 2016 Apr; 38(4):651-7. PubMed ID: 26696535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Biosynthesis of Plasmid DNA from Escherichia coli Applying Experimental Design.
    Passarinha LA
    Methods Mol Biol; 2021; 2197():135-150. PubMed ID: 32827135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of new plasmid DNA vaccine vectors with R1-based replicons.
    Bower DM; Prather KL
    Microb Cell Fact; 2012 Aug; 11():107. PubMed ID: 22889338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transposon leads to contamination of clinical pDNA vaccine.
    van der Heijden I; Gomez-Eerland R; van den Berg JH; Oosterhuis K; Schumacher TN; Haanen JB; Beijnen JH; Nuijen B
    Vaccine; 2013 Jul; 31(32):3274-80. PubMed ID: 23707695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of growth conditions on plasmid DNA production.
    Silva F; Passarinha L; Sousa F; Queiroz JA; Domingues FC
    J Microbiol Biotechnol; 2009 Nov; 19(11):1408-14. PubMed ID: 19996695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo creation of MG1655-derived E. coli strains specifically designed for plasmid DNA production.
    Gonçalves GA; Prazeres DM; Monteiro GA; Prather KL
    Appl Microbiol Biotechnol; 2013 Jan; 97(2):611-20. PubMed ID: 22885693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified Escherichia coli B (BL21), a superior producer of plasmid DNA compared with Escherichia coli K (DH5alpha).
    Phue JN; Lee SJ; Trinh L; Shiloach J
    Biotechnol Bioeng; 2008 Nov; 101(4):831-6. PubMed ID: 18814292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving DNA vaccine performance through vector design.
    Williams JA
    Curr Gene Ther; 2014; 14(3):170-89. PubMed ID: 25142448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmid-DNA lipid and polymeric nanovaccines: a new strategic in vaccines development.
    Tejeda-Mansir A; García-Rendón A; Guerrero-Germán P
    Biotechnol Genet Eng Rev; 2019 Apr; 35(1):46-68. PubMed ID: 30587085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fermentation strategy on the characteristics of plasmid DNA production.
    O'Kennedy RD; Ward JM; Keshavarz-Moore E
    Biotechnol Appl Biochem; 2003 Feb; 37(Pt 1):83-90. PubMed ID: 12578555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.
    Williams JA; Carnes AE; Hodgson CP
    Biotechnol Adv; 2009; 27(4):353-70. PubMed ID: 19233255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating metabolic stress and plasmid stability in plasmid DNA production by Escherichia coli.
    Silva F; Queiroz JA; Domingues FC
    Biotechnol Adv; 2012; 30(3):691-708. PubMed ID: 22244816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.